The weekly litigation news digest is live. Subscribe now

Pneumococcal Polysaccharide Conjugate Vaccine

Patent No. EP3017827 (titled "Pneumococcal Polysaccharide Conjugate Vaccine") was filed by Glaxosmithkline on Dec 20, 2006. The application was issued on Nov 7, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3017827

GLAXOSMITHKLINE
Application Number
EP15195398A
Filing Date
Dec 20, 2006
Status
Revoked
Apr 4, 2025
Publication Date
Nov 7, 2018